Sunday, January 7, 2018
WASHINGTON -- A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting therapies.
This story is only available from our archives.
Get Unlimited Access. Subscribe Today
ACCESS. ANYTIME. ANYWHERE.
We hope you've enjoyed your preview of HOTSR.com.
You've now read the maximum number of stories available without a subscription.
Subscribe now for complete and uninterrupted access to the best local news.